ZL
Therapeutic Areas
Ordaos Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| miniPRO™ Binders to HER2 | Oncology (HER2+) | Pre-clinical |
| Optimized VHH vs. SARS-CoV-2 | Infectious Disease | Pre-clinical |
| Joint Development for AML | Acute Myeloid Leukemia | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| miniPRO™ Binders to HER2 | Oncology (HER2+) | Pre-clinical |
| Optimized VHH vs. SARS-CoV-2 | Infectious Disease | Pre-clinical |
| Joint Development for AML | Acute Myeloid Leukemia | Pre-clinical |